29 results
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals Inc
8 May 24
Mirum Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
4:04pm
transporter (IBAT). Volixibat may offer a novel approach in the treatment of adult cholestatic diseases by blocking the recycling of bile acids, through
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals Inc
28 Feb 24
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update
4:05pm
bile acid transporter (IBAT). Volixibat may offer a novel approach in the treatment of adult cholestatic diseases by blocking the recycling of bile acids
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals Inc
8 Jan 24
Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
8:30am
a novel approach in the treatment of adult cholestatic diseases by blocking the recycling of bile acids, through inhibition of ASBT, thereby reducing
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals Inc
2 Nov 23
Results of Operations and Financial Condition
4:06pm
of adult cholestatic diseases by blocking the recycling of bile acids, through inhibition of ASBT, thereby reducing bile acids systemically
8-K
EX-99.1
nwfy0n8qfakmfnv1u98
3 Aug 23
Results of Operations and Financial Condition
4:05pm
8-K
EX-99.1
7kdbbtu 2rwu
4 May 23
Results of Operations and Financial Condition
4:02pm
8-K
EX-99.1
b9wpo2
9 Nov 22
Results of Operations and Financial Condition
7:30am
8-K
EX-99.1
btlnyli
4 Aug 22
Results of Operations and Financial Condition
4:03pm
8-K
EX-99.1
a1imgr5e93s
5 May 22
Results of Operations and Financial Condition
8:05am
8-K
EX-99.1
1a9 vwe3zpmgkxo7u3n3
9 Mar 22
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update
4:05pm
8-K
EX-99.1
npblw0knl6qdu6uc9mt
15 Nov 21
Mirum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
4:06pm
8-K
EX-99.1
x0e z791bgq0ez
5 Aug 21
Mirum Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update
4:36pm
8-K
EX-99.1
3425j
6 May 21
Mirum Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update
4:06pm
10-K
res0ln6
12 Mar 20
Annual report
4:16pm
424B4
jxa0ho16 11
9 Jan 20
Prospectus supplement with pricing info
5:11pm
DRS
EX-10.15
b082749xun9ced
27 Dec 19
Draft registration statement
12:00am